These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 2898508

  • 1. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD, Murray RJ, Edwards CF, Rickinson AB.
    J Exp Med; 1988 Jun 01; 167(6):1811-24. PubMed ID: 2898508
    [Abstract] [Full Text] [Related]

  • 2. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R, Burrows SR, Suhrbier A, Jacob CA, Griffin H, Misko IS, Sculley TB, Rowe M, Rickinson AB, Moss DJ.
    J Immunol; 1993 Jun 01; 150(11):5154-62. PubMed ID: 7684421
    [Abstract] [Full Text] [Related]

  • 3. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H, Rowe M, Murray R, Brooks J, Rickinson A.
    Eur J Immunol; 1992 Jul 01; 22(7):1741-8. PubMed ID: 1378014
    [Abstract] [Full Text] [Related]

  • 4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG, Zhang QJ, Gavioli R, De Campos-Lima PO, Murray RJ, Brooks J, Griffin H, Ploegh H, Rickinson AB.
    Int Immunol; 1992 Nov 01; 4(11):1283-92. PubMed ID: 1282031
    [Abstract] [Full Text] [Related]

  • 5. Low expression of lymphocyte function-associated antigen (LFA)-1 and LFA-3 adhesion molecules is a common trait in Burkitt's lymphoma associated with and not associated with Epstein-Barr virus.
    Billaud M, Rousset F, Calender A, Cordier M, Aubry JP, Laisse V, Lenoir GM.
    Blood; 1990 May 01; 75(9):1827-33. PubMed ID: 1691936
    [Abstract] [Full Text] [Related]

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR.
    Eur J Immunol; 1995 May 01; 25(5):1374-84. PubMed ID: 7774641
    [Abstract] [Full Text] [Related]

  • 7. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
    Quillet-Mary A, Cavarec L, Kermarrec N, Marchiol-Fournigault C, Gil ML, Conjeaud H, Fradelizi D.
    Int J Cancer; 1991 Feb 01; 47(3):473-9. PubMed ID: 1704356
    [Abstract] [Full Text] [Related]

  • 8. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD, Rowe M, Rickinson AB.
    J Gen Virol; 1990 Jul 01; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [Abstract] [Full Text] [Related]

  • 9. The LFA-1/ICAM cell adhesion pathway is involved in tumor-cell lysis mediated by bispecific monoclonal-antibody-targeted T lymphocytes.
    Ferrini S, Sforzini S, Cambiaggi A, Poggi A, Meazza R, Canevari S, Colnaghi MI, Moretta L.
    Int J Cancer; 1994 Mar 15; 56(6):846-52. PubMed ID: 7907079
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG, Torsteindottir S, Colombani J, Brautbar C, Klein E, Klein G.
    Proc Natl Acad Sci U S A; 1987 Jul 15; 84(13):4567-71. PubMed ID: 3037521
    [Abstract] [Full Text] [Related]

  • 11. Viruses and cancer risks: outgrowth of Epstein-Barr virus-positive Burkitt's lymphoma in the immune host.
    Rickinson AB, Gregory CD, Young LS.
    Med Oncol Tumor Pharmacother; 1987 Jul 15; 4(3-4):177-86. PubMed ID: 2831439
    [Abstract] [Full Text] [Related]

  • 12. IL-4 induces LFA-1 and LFA-3 expression on Burkitt's lymphoma cell lines. Requirement of additional activation by phorbol myristate acetate for induction of homotypic cell adhesions.
    Rousset F, Billaud M, Blanchard D, Figdor C, Lenoir GM, Spits H, De Vries JE.
    J Immunol; 1989 Sep 01; 143(5):1490-8. PubMed ID: 2547869
    [Abstract] [Full Text] [Related]

  • 13. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB, Murray RJ, Brooks J, Griffin H, Moss DJ, Masucci MG.
    Cancer Surv; 1992 Sep 01; 13():53-80. PubMed ID: 1330300
    [Abstract] [Full Text] [Related]

  • 14. Functional evidence that intercellular adhesion molecule-1 (ICAM-1) is a ligand for LFA-1-dependent adhesion in T cell-mediated cytotoxicity.
    Makgoba MW, Sanders ME, Ginther Luce GE, Gugel EA, Dustin ML, Springer TA, Shaw S.
    Eur J Immunol; 1988 Apr 01; 18(4):637-40. PubMed ID: 2896596
    [Abstract] [Full Text] [Related]

  • 15. Both LFA-1-positive and -deficient T cell clones require the CD2/LFA-3 interaction for specific cytolytic activation.
    Van de Wiel-van Kemenade E, Te Velde AA, De Boer AJ, Weening RS, Fischer A, Borst J, Melief CJ, Figdor CG.
    Eur J Immunol; 1992 Jun 01; 22(6):1467-75. PubMed ID: 1376259
    [Abstract] [Full Text] [Related]

  • 16. CD2/LFA-3 or LFA-1/ICAM-1 but not CD28/B7 interactions can augment cytotoxicity by virus-specific CD8+ cytotoxic T lymphocytes.
    de Waal Malefyt R, Verma S, Bejarano MT, Ranes-Goldberg M, Hill M, Spits H.
    Eur J Immunol; 1993 Feb 01; 23(2):418-24. PubMed ID: 7679643
    [Abstract] [Full Text] [Related]

  • 17. ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis.
    Braakman E, Goedegebuure PS, Vreugdenhil RJ, Segal DM, Shaw S, Bolhuis RL.
    Int J Cancer; 1990 Sep 15; 46(3):475-80. PubMed ID: 1975566
    [Abstract] [Full Text] [Related]

  • 18. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R, Albi N, Zarcone D, Grossi CE, Velardi A.
    Eur J Immunol; 1992 Aug 15; 22(8):2047-53. PubMed ID: 1379184
    [Abstract] [Full Text] [Related]

  • 19. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
    Abe M, Tasaki K, Tominaga K, Fukuhara S, Imai S, Osato T, Wakasa H.
    Cancer; 1992 Feb 01; 69(3):763-71. PubMed ID: 1309680
    [Abstract] [Full Text] [Related]

  • 20. Stimulation with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines generates HLA class I-specific CTLs with different target cell avidity.
    Torsteinsdottir S, Cuomo L, Klein E, Masucci MG.
    Cell Immunol; 1991 Oct 15; 137(2):501-13. PubMed ID: 1654213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.